Arcadia Biosciences (RKDA) Misses Q3 EPS by 2c

Arcadia Biosciences (NASDAQ: RKDA) reported Q3 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $1.08 million versus the consensus estimate of $2.1 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• BayCom Corp (BCML) Misses Q1 EPS by 4c
• SB Financial Group (SBFG) Tops Q1 EPS by 1c
• Metropolitan Bank Holding Corp (MCB) Tops Q1 EPS by 12c